SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1977MNTA ‘ReadMeFirst’ updated: share-price upside in best-case and “less than bestDewDiligence_on_SI-5/17/2009
1976<i>Even if generic Lovenox is approved today (<b>which doesn't sDewDiligence_on_SI-5/12/2009
1975Jefferies note today... Teva Pharmaceutical (NASDAQ: TEVA) Copaxone Generic Risrkrw-5/12/2009
1974MNTA ‘ReadMeFirst’ updated (again): how MNTA executed against its 2008 internalDewDiligence_on_SI-5/10/2009
1973MNTA ‘ReadMeFirst’ updated for 1Q09 financial results, cash-usage projections, aDewDiligence_on_SI-5/8/2009
1972Only ONE analyst covering??? SeekingAlpha: Momenta Pharmaceuticals Q1 2009 Earnmopgcw-5/8/2009
1971teva munching mnta for generic copaxone will be the day. Considering i'd estrkrw-5/6/2009
1970The FTC’s batting average in court cases involving generic drugs is lower than VDewDiligence_on_SI-5/5/2009
1969FTC would block teva from acquiring mnta. Unless they divested generic copaxone.rkrw-5/5/2009
1968Copaxone is becoming such a big part of Teva’s profitability that Teva will haveDewDiligence_on_SI-5/5/2009
1967I think Tysabri is going to start picking up more momentum. Be it this quarter orkrw-5/5/2009
1966Copaxone Continues to Clean Tysabri’s Clock in US Market: siliconinvestor.comDewDiligence_on_SI-5/5/2009
1965Supreme Court Denies Sanofi Appeal In Lovenox Patent Case>SNY Apr 27, 2009 1LJM-4/27/2009
1964There's no timing guidance other than mnta/sandoz are prepared to launch thirkrw-4/21/2009
1963I have lost track having exited way too early way back when - when is ANDA timinRobohogs-4/21/2009
1962Well, it doesn't hurt to put it up, but probably yes. Remember, AACR does ntuck-4/20/2009
1961<i>Are you suggesting that my breaking news is at least a week out of dateDewDiligence_on_SI-4/20/2009
1960Are you suggesting that my breaking news is at least a week out of date? ;-) SIan@SI-4/20/2009
1959siliconinvestor.comDewDiligence_on_SI-4/20/2009
19588:03AM Momenta Pharma announces results from preclinical study of drug candidateIan@SI-4/20/2009
1957Oops—make that <i>rearing</i> (not hearing). LOLDewDiligence_on_SI-3/19/2009
1956The ghost of Exanta is hearing its head.DewDiligence_on_SI-3/17/2009
1955* MARCH 17, 2009, 10:47 A.M. ET <b>FDA: Proposed Drug Rivaroxaban Has BleIan@SI-3/17/2009
1954Public release date: 12-Mar-2009 Contact: Michelle Gailiun michelle.gailiun@dukIan@SI-3/12/2009
1953you would think they would learn...old dog new tricks i guess.mopgcw-3/12/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News